The Niacin Debate Continues: Higher Doses, Please

Article Type
Changed
Tue, 05/03/2022 - 16:03
Display Headline
The Niacin Debate Continues: Higher Doses, Please

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 26(7)
Publications
Topics
Page Number
12
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 26(7)
Issue
Federal Practitioner - 26(7)
Page Number
12
Page Number
12
Publications
Publications
Topics
Article Type
Display Headline
The Niacin Debate Continues: Higher Doses, Please
Display Headline
The Niacin Debate Continues: Higher Doses, Please
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

We Know Less than We Think, Part 2: Aspirin Therapy in Diabetes Not a Given After All

Article Type
Changed
Tue, 05/03/2022 - 16:03
Display Headline
We Know Less than We Think, Part 2: Aspirin Therapy in Diabetes Not a Given After All

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 26(4)
Publications
Topics
Page Number
10
Legacy Keywords
aspirin, diabetes, diabetic, cardiovascular, disease, atherosclerosis, atherosclerotic, adverse effects, side effects, Japanese Primary, Prevention, of, Atherosclerosis, with, Aspirin, for, Diabetes, JPAD, trial
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 26(4)
Issue
Federal Practitioner - 26(4)
Page Number
10
Page Number
10
Publications
Publications
Topics
Article Type
Display Headline
We Know Less than We Think, Part 2: Aspirin Therapy in Diabetes Not a Given After All
Display Headline
We Know Less than We Think, Part 2: Aspirin Therapy in Diabetes Not a Given After All
Legacy Keywords
aspirin, diabetes, diabetic, cardiovascular, disease, atherosclerosis, atherosclerotic, adverse effects, side effects, Japanese Primary, Prevention, of, Atherosclerosis, with, Aspirin, for, Diabetes, JPAD, trial
Legacy Keywords
aspirin, diabetes, diabetic, cardiovascular, disease, atherosclerosis, atherosclerotic, adverse effects, side effects, Japanese Primary, Prevention, of, Atherosclerosis, with, Aspirin, for, Diabetes, JPAD, trial
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

What Should We Do About Proteinuria?

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
What Should We Do About Proteinuria?

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 26(1)
Publications
Topics
Page Number
8
Legacy Keywords
proteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockersproteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockers
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 26(1)
Issue
Federal Practitioner - 26(1)
Page Number
8
Page Number
8
Publications
Publications
Topics
Article Type
Display Headline
What Should We Do About Proteinuria?
Display Headline
What Should We Do About Proteinuria?
Legacy Keywords
proteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockersproteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockers
Legacy Keywords
proteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockersproteinuria, kidneys, kidney, renal, microalbuminuria, endothelial, cardiovascular disease, angiotensin II receptor blockers
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Niacin for Patients with Diabetes?

Article Type
Changed
Tue, 05/03/2022 - 16:03
Display Headline
Niacin for Patients with Diabetes?

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(12)
Publications
Topics
Page Number
11
Legacy Keywords
niacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statinsniacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statins
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(12)
Issue
Federal Practitioner - 25(12)
Page Number
11
Page Number
11
Publications
Publications
Topics
Article Type
Display Headline
Niacin for Patients with Diabetes?
Display Headline
Niacin for Patients with Diabetes?
Legacy Keywords
niacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statinsniacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statins
Legacy Keywords
niacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statinsniacin, lipoprotein cholesterol, HDL-C, LDL-C, lipid, lipids, diabetes, glycemic control, triglycerides, statins
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Treating Hypertension: How Low Should We Go?

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Treating Hypertension: How Low Should We Go?

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(10)
Publications
Topics
Page Number
7
Legacy Keywords
Hypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensivesHypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensives
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(10)
Issue
Federal Practitioner - 25(10)
Page Number
7
Page Number
7
Publications
Publications
Topics
Article Type
Display Headline
Treating Hypertension: How Low Should We Go?
Display Headline
Treating Hypertension: How Low Should We Go?
Legacy Keywords
Hypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensivesHypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensives
Legacy Keywords
Hypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensivesHypertension, blood pressure, BP, cardiovascular disease, hypertension, antihypertensives
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

We Know Less than We Think

Article Type
Changed
Tue, 05/03/2022 - 16:04
Display Headline
We Know Less than We Think

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(9)
Publications
Topics
Page Number
13
Legacy Keywords
diabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, thinkdiabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, think
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(9)
Issue
Federal Practitioner - 25(9)
Page Number
13
Page Number
13
Publications
Publications
Topics
Article Type
Display Headline
We Know Less than We Think
Display Headline
We Know Less than We Think
Legacy Keywords
diabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, thinkdiabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, think
Legacy Keywords
diabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, thinkdiabetes, cardiovascular events, CV, menopause, postmenopausal, estrogen, estrogens, Women's Health Initiative, stroke, coronary heart disease, glucose, morbidity, mortality, Action to Control Cardiovascular Risk, ACCORD, glycemia, glycemic control, hypertension, lipid, conventional treatment, aggressive treatment, editorial, we, know, less, than, think
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Early Intervention for Diabetes-Related Renal Disease: Don't Let Rising Creatine Block the Way

Article Type
Changed
Tue, 05/03/2022 - 16:04
Display Headline
Early Intervention for Diabetes-Related Renal Disease: Don't Let Rising Creatine Block the Way

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(6)
Publications
Topics
Page Number
12
Legacy Keywords
diabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneysdiabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneys
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(6)
Issue
Federal Practitioner - 25(6)
Page Number
12
Page Number
12
Publications
Publications
Topics
Article Type
Display Headline
Early Intervention for Diabetes-Related Renal Disease: Don't Let Rising Creatine Block the Way
Display Headline
Early Intervention for Diabetes-Related Renal Disease: Don't Let Rising Creatine Block the Way
Legacy Keywords
diabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneysdiabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneys
Legacy Keywords
diabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneysdiabetes, renal, disease, endocrinology, rennin-angiotensin system, RAS, angiotensin converting enzyme, ACE, angiotensin receptor blockers, ARB, ARBs, direct rennin inhibitors, DRI, DRIs, aldosterone blockers, serum creatinine, SCr, kidney, kidneys
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Testosterone Replacement Therapy in the VA Setting

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Testosterone Replacement Therapy in the VA Setting
Men's Sexual Health Consult Collection

Article PDF
Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Publications
Topics
Page Number
1–25
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Article PDF
Article PDF
Men's Sexual Health Consult Collection
Men's Sexual Health Consult Collection

Page Number
1–25
Page Number
1–25
Publications
Publications
Topics
Article Type
Display Headline
Testosterone Replacement Therapy in the VA Setting
Display Headline
Testosterone Replacement Therapy in the VA Setting
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Article Source

Citation Override
Fed Pract. 2008;25(suppl 2):1–25.
PURLs Copyright

Inside the Article

Article PDF Media

Improving the Physician-Patient Relationship: Take a Lesson from Your Students

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Improving the Physician-Patient Relationship: Take a Lesson from Your Students

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(4)
Publications
Page Number
7
Legacy Keywords
teaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationshipteaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationship
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(4)
Issue
Federal Practitioner - 25(4)
Page Number
7
Page Number
7
Publications
Publications
Article Type
Display Headline
Improving the Physician-Patient Relationship: Take a Lesson from Your Students
Display Headline
Improving the Physician-Patient Relationship: Take a Lesson from Your Students
Legacy Keywords
teaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationshipteaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationship
Legacy Keywords
teaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationshipteaching, students, humanistic, humanism, humanity, emotion, emotional, comfort, lesson, improving, physician, patient, relationship
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Obesity Epidemic: Let's Get Real

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
The Obesity Epidemic: Let's Get Real

Article PDF
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 25(2)
Publications
Page Number
17
Legacy Keywords
obesity, epidemic, real, editorial, endocrinology, overweight, referralobesity, epidemic, real, editorial, endocrinology, overweight, referral
Sections
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
Article PDF

Issue
Federal Practitioner - 25(2)
Issue
Federal Practitioner - 25(2)
Page Number
17
Page Number
17
Publications
Publications
Article Type
Display Headline
The Obesity Epidemic: Let's Get Real
Display Headline
The Obesity Epidemic: Let's Get Real
Legacy Keywords
obesity, epidemic, real, editorial, endocrinology, overweight, referralobesity, epidemic, real, editorial, endocrinology, overweight, referral
Legacy Keywords
obesity, epidemic, real, editorial, endocrinology, overweight, referralobesity, epidemic, real, editorial, endocrinology, overweight, referral
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media